Payer Startup aims to be a ‘no-compromises’ PBM, but the market may need convincing
FierceHealthcare’s Anastassia Gliadkovskaya examines how Prescryptive plans to shake up the PBM market.
Close Menu
FierceHealthcare’s Anastassia Gliadkovskaya examines how Prescryptive plans to shake up the PBM market.
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…
Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…